RECELL Autologous Cell Harvesting Device - MEDICAID - KENTUCKY (New)
Summary
Humana Kentucky Medicaid has issued a NEW policy (effective 08/12/2026) establishing coverage for the RECELL autologous cell harvesting device for specific wound and vitiligo treatment indications. The device is now a covered service under Kentucky Medicaid with mandatory prior authorization requirements. Billing team must implement prior auth workflows and ensure claims are coded using C1832 or C8002 HCPCS codes only for approved indications.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.